Vaccine Trials
Recent Highlights
All Stories for Vaccine Trials
Volunteers needed for different kinds of COVID-19 vaccines, even for frontrunners in vaccine race
•Multiple vaccines will be needed to meet global demand, raising concern that studies that still need to sign up thousands of volunteers.
COVID-19 vaccine trials 'can't detect' reduced risk of hospitalisation, death: Expert
•WHO has identified 42 candidate vaccines in clinical trials, ten of which are in advanced 'Phase 3 trials in human volunteers.
‘Significant movement' on Phase-3 trial, manufacture of Russia's Sputnik V vaccine, says NITI Aayog
•Dr VK Paul, who chairs the national expert group on COVID-19 vaccine administration, said that the government of India attaches 'great importance to this offer of partnership from a friend'
Uncertainty over long-term immune response has implications for efficacy of COVID-19 vaccine, say experts
•In an editorial in the ICMR's, Indian Journal of Medical Research, experts also said that continued use of masks and other measures may be advocated if evidence shows a possible role of asymptomatic persons in COVID-19 transmission
Russia and India in talks about manufacturing deal for Russia's COVID-19 vaccine Sputnik V
Tech2 News Staff •Pfizer announces $1.95 billion deal to produce 100 million doses of coronavirus vaccine by year-end
•Pfizer said that large-scale safety and efficacy trials were to begin this month, with a regulatory review set for as early as October, although nothing was guaranteed.
AIIMS panel gives nod to begin human clinical trial of COVID-19 vaccine Covaxin from 20 July
•Covaxin, Bharat Biotech's COVID-19 vaccine candidate, has been developed in collaboration with the ICMR and NIV
Pfizer CEO says COVID-19 vaccine likely to be ready by October this year; 'will have enough evidence of safety, efficacy'
Fp Staff •Pfizer is working with German firm Biontech for several possible vaccines in Europe and the United States, said the report.
Highly-anticipated coronavirus vaccine will be produced at large scale, won’t be expensive, says Oxford University professor
•A keenly-watched COVID-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up
COVID-19 Global Roundup: Over 1.5 million cases, US and UK see record number of deaths in a day, death toll of doctors reaches 100 in Italy
Myupchar •COVID-19 Global Roundup: Over 1.5 million cases, US and UK see record number of deaths in a day, death toll of doctors reaches 100 in Italy There are now over 1.53 million confirmed cases of COVID-19 across the world, and nearly 89,800 people have lost their lives to it. At the same time, over 340,000 people have recovered from the disease as well. Spain reported 683 deaths on Wednesday, which was slightly lower compared to previous days